Advertisment

Understanding Crohn's Disease: Symptoms, Causes, and Advances in Treatment

author-image
Zara Nwosu
New Update
Understanding Crohn's Disease: Symptoms, Causes, and Advances in Treatment

Understanding Crohn's Disease: Symptoms, Causes, and Advances in Treatment

Advertisment

Crohn's disease is a complex inflammatory disorder that primarily targets the gastrointestinal tract. However, it can also affect other bodily organs like the skin, joints, bones, eyes, kidneys, and liver. The symptoms primarily involve the intestinal system, making it a challenging condition to diagnose and manage. The disease course can vary widely among patients, with some experiencing prolonged remission, while others suffer from a chronic progressive form of the disease. Factors such as genetics, environment, and microbial elements contribute to its multifactorial etiology.

Advertisment

Understanding the Impact of Crohn's Disease

As an Inflammatory Bowel Disease (IBD), Crohn's disease can cause segmental inflammation that can affect any part of the digestive system, leading to the formation of fistulas and associated complications. Extra-intestinal manifestations are also common, and the disease can have a significant impact on patients' quality of life. It can affect physical and mental health as well as work performance, imposing a substantial burden on healthcare systems.

Assessing Disease Activity

Advertisment

Assessing disease activity in Crohn's patients involves a combination of symptom assessment, biochemical assessment, and endoscopic radiologic evaluation. Laboratory markers of inflammation, such as C-reactive protein and fecal calprotectin, provide useful information for assessing the current inflammatory burden of Crohn's disease. An elevated level of C-reactive protein is associated with CD-related hospitalization and subsequent CD-related intestinal resection even in patients in clinical remission.

Challenges and Advances in Treatment

Treating Crohn's disease has been a challenge for the medical community. While anti-TNF therapies are a common treatment option, many patients are refractory to this form of treatment. However, the recent FDA approval of upadacitinib and risankizumab has shown positive results in clinical trials. There are also new delivery modes for existing therapies and potential future treatments such as etrasimod and stem therapy. Despite these advances, genetic manipulation may not offer a cure for Crohn's disease. The need for individualized treatment precision and the identification of adverse effects remain crucial.

Advertisment

New Hope for Crohn's Disease Patients

The past year has seen a multitude of FDA approvals for treatments for IBD, including Crohn's disease. Approvals range from IL 23 and JAK inhibitors to biologics and subcutaneous treatment administrations that have redefined what it means to treat IBD. Game-changing medications like mirikizumab, upadacitinib, and etrasimod have been approved, offering new hope for patients suffering from this debilitating condition. Additionally, FDA approvals for biosimilars and new treatment administration options have increased access to life-changing therapies for patients with Crohn's disease.

Stay Informed About Crohn's Disease

Staying informed about the latest research and treatments for Crohn's disease is crucial for patients and medical professionals alike. Websites like 'Crohn's Disease News' provide up-to-date information, free email newsletters, and social network updates, encouraging feedback and questions from its users. By staying informed and engaged, patients can better manage their condition and live healthier lives.

Inflammatory Bowel Disease Crohn's Disease
Advertisment
Chat with Dr. Medriva !